• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工因素评估 HeartMate 3 左心室辅助设备周边设备:一项基于眼动追踪的模拟研究。

Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study.

机构信息

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.

出版信息

J Med Syst. 2023 May 3;47(1):58. doi: 10.1007/s10916-023-01950-3.

DOI:10.1007/s10916-023-01950-3
PMID:37133553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10156833/
Abstract

BACKGROUND

Despite recent design improvements, human factors issues continue to challenge left ventricular assist device (LVAD) therapy. The aim of this study was to evaluate user experience of former non-HeartMate 3 (HM3) LVAD patients post heart transplantation (HTX) and laypersons (LP) with HM3 LVAD peripherals in simulated everyday and emergency scenarios.

METHODS

This single center cohort study included untrained HTX and LP. Seven scenarios, including battery exchanges (without alarm, advisory alarm, dim light, consolidated bag), change of power supply, driveline dis-/reconnection and controller exchange were simulated. Subjects' gaze behavior was recorded using eye tracking technology. Success rate, pump-off-time, duration to success (DTS), percental fixation duration per areas of interest and post-scenario-survey results were defined as outcome measures.

RESULTS

Thirty subjects completed 210 scenarios, initially solving 82.4% (HTX vs. LP, p = 1.00). Changing power supply revealed highest complexity (DTS = 251 ± 93s, p = 0.76): 26.7% succeeded at first attempt (p = 0.68), 56.7% at second attempt, with significantly more LP failing (p = 0.04), resulting in 10 hazards from driveline disconnections (pump-off-time 2-118s, p = 0.25). Comparison on initial success showed differences in fixation durations for seven areas of interest (p < 0.037). Decreasing DTS during battery exchanges (p < 0.001) indicate high learnability. Exchanging batteries within the bag took longer (median DTS = 75.0 (IQR = 45.0)s, p = 0.09), especially in elderly subjects (r = 0.61, p < 0.001). Subjects with less initial success were more afraid of making mistakes (p = 0.048).

CONCLUSION

This eye tracking based human factors study provided insights into user experiences in handling HM3 peripherals. It highlights unintuitive and hazardous characteristics, providing guidance for future user-centered design of LVAD wearables.

摘要

背景

尽管最近的设计有所改进,但人为因素问题仍然给左心室辅助装置(LVAD)治疗带来挑战。本研究旨在评估接受心脏移植(HTX)后的前非 HeartMate 3(HM3)LVAD 患者和 HM3 LVAD 外周设备的非专业人员在模拟日常和紧急情况下的用户体验。

方法

这是一项单中心队列研究,包括未经训练的 HTX 和 LP。模拟了七种情况,包括电池更换(无警报、警告警报、光线昏暗、合并袋)、更换电源、驱动线断开/重新连接和控制器更换。使用眼动追踪技术记录受试者的注视行为。成功率、泵停时间、成功时间(DTS)、每个关注区域的固定时间百分比和场景后调查结果被定义为结果测量。

结果

30 名受试者完成了 210 个场景,最初成功率为 82.4%(HTX 与 LP,p=1.00)。更换电源的复杂性最高(DTS=251±93s,p=0.76):首次尝试成功率为 26.7%(p=0.68),第二次尝试成功率为 56.7%,LP 失败率明显更高(p=0.04),导致 10 次因驱动线断开而出现危险(泵停时间为 2-118s,p=0.25)。在初始成功率方面的比较显示了七个关注区域的注视时间差异(p<0.037)。电池更换过程中 DTS 的降低(p<0.001)表明了较高的可学习性。在袋子内更换电池需要更长的时间(中位数 DTS=75.0(IQR=45.0)s,p=0.09),尤其是在老年受试者中(r=0.61,p<0.001)。初始成功率较低的受试者更容易害怕犯错(p=0.048)。

结论

这项基于眼动追踪的人为因素研究提供了对 HM3 外周设备使用体验的深入了解。它突出了非直观和危险的特点,为未来以 LVAD 可穿戴设备为中心的用户设计提供了指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/54854d9e9ecb/10916_2023_1950_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/73bfb2d8f712/10916_2023_1950_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/ce21201af980/10916_2023_1950_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/b2328fdc8f23/10916_2023_1950_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/54854d9e9ecb/10916_2023_1950_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/73bfb2d8f712/10916_2023_1950_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/ce21201af980/10916_2023_1950_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/b2328fdc8f23/10916_2023_1950_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d7/10156833/54854d9e9ecb/10916_2023_1950_Fig4_HTML.jpg

相似文献

1
Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study.人工因素评估 HeartMate 3 左心室辅助设备周边设备:一项基于眼动追踪的模拟研究。
J Med Syst. 2023 May 3;47(1):58. doi: 10.1007/s10916-023-01950-3.
2
It's not only the pump: Assessment of human factors of wearable components and user experience of patients with left ventricular assist devices.问题不仅在于泵:对可穿戴组件的人为因素及左心室辅助装置患者的用户体验进行评估。
J Heart Lung Transplant. 2023 Apr;42(4):466-477. doi: 10.1016/j.healun.2022.12.015. Epub 2022 Dec 27.
3
Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.使用 HeartMate 3 进行持久左心室辅助装置置换的早期结果。
J Thorac Cardiovasc Surg. 2020 Jul;160(1):132-139.e1. doi: 10.1016/j.jtcvs.2019.09.151. Epub 2019 Oct 16.
4
Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.HeartMate 3患者模块化电缆更换与HeartMate II患者传统驱动线修复的结果对比。
Artif Organs. 2023 Feb;47(2):380-386. doi: 10.1111/aor.14413. Epub 2022 Oct 8.
5
First experiences with HeartMate 3 follow-up and adverse events.首份 HeartMate 3 随访和不良事件经验报告。
J Thorac Cardiovasc Surg. 2017 Jul;154(1):173-178. doi: 10.1016/j.jtcvs.2017.01.045. Epub 2017 Feb 9.
6
One-year outcomes with the HeartMate 3 left ventricular assist device.HeartMate 3 左心室辅助装置的一年临床结果。
J Thorac Cardiovasc Surg. 2018 Aug;156(2):662-669. doi: 10.1016/j.jtcvs.2018.01.083. Epub 2018 Feb 13.
7
Eye Tracking Supported Human Factors Testing Improving Patient Training.眼动追踪支持的人因测试改善患者培训。
J Med Syst. 2021 Mar 25;45(5):55. doi: 10.1007/s10916-021-01729-4.
8
Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.随机试验:左心室辅助装置作为终末期心力衰竭患者的治疗目标与指南指导的药物治疗的比较。SWEdish evaluation of left Ventricular Assist Device(SweVAD)试验的原理和设计。
Eur J Heart Fail. 2020 Apr;22(4):739-750. doi: 10.1002/ejhf.1773. Epub 2020 Feb 26.
9
Use of left ventricular assist device (HeartMate II): a Singapore experience.左心室辅助装置(HeartMate II)的应用:新加坡的经验
Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.
10
First series of left ventricular assist device exchanges to HeartMate 3.首次将左心室辅助装置更换为HeartMate 3系列。
Eur J Cardiothorac Surg. 2017 May 1;51(5):887-892. doi: 10.1093/ejcts/ezx010.

本文引用的文献

1
It's not only the pump: Assessment of human factors of wearable components and user experience of patients with left ventricular assist devices.问题不仅在于泵:对可穿戴组件的人为因素及左心室辅助装置患者的用户体验进行评估。
J Heart Lung Transplant. 2023 Apr;42(4):466-477. doi: 10.1016/j.healun.2022.12.015. Epub 2022 Dec 27.
2
The Society of Thoracic Surgeons Intermacs 2022 Annual Report: Focus on the 2018 Heart Transplant Allocation System.胸外科医师协会Intermacs 2022年度报告:聚焦2018年心脏移植分配系统
Ann Thorac Surg. 2023 Feb;115(2):311-327. doi: 10.1016/j.athoracsur.2022.11.023. Epub 2022 Dec 1.
3
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
在 MOMENTUM 3 随机试验中,完全磁悬浮与轴流左心室辅助装置患者的 5 年结果。
JAMA. 2022 Sep 27;328(12):1233-1242. doi: 10.1001/jama.2022.16197.
4
Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.全球最佳实践共识:杂交离心流左心室辅助装置支持患者的长期管理。
J Thorac Cardiovasc Surg. 2022 Oct;164(4):1120-1137.e2. doi: 10.1016/j.jtcvs.2022.03.035. Epub 2022 Apr 21.
5
Video-based reflection on neonatal interventions during COVID-19 using eye-tracking glasses: an observational study.基于眼动追踪眼镜的 COVID-19 期间新生儿干预措施的视频反思:一项观察性研究。
Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107(2):156-160. doi: 10.1136/archdischild-2021-321806. Epub 2021 Aug 19.
6
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.MOMENTUM 3 关键试验和持续准入方案研究阶段的长期结果初步结果:2200 例 HeartMate 3 左心室辅助装置植入的研究。
Eur J Heart Fail. 2021 Aug;23(8):1392-1400. doi: 10.1002/ejhf.2211. Epub 2021 May 18.
7
Eye Tracking Supported Human Factors Testing Improving Patient Training.眼动追踪支持的人因测试改善患者培训。
J Med Syst. 2021 Mar 25;45(5):55. doi: 10.1007/s10916-021-01729-4.
8
Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources.在分配稀缺医疗资源时使用临床衰弱量表。
Can Geriatr J. 2020 Sep 1;23(3):210-215. doi: 10.5770/cgj.23.463. eCollection 2020 Sep.
9
Value of Eye-Tracking Data for Classification of Information Processing-Intensive Handling Tasks: Quasi-Experimental Study on Cognition and User Interface Design.眼动追踪数据在信息处理密集型操作任务分类中的价值:关于认知与用户界面设计的准实验研究
JMIR Hum Factors. 2020 Jun 3;7(2):e15581. doi: 10.2196/15581.
10
Simulation in perfusion: evaluating the efficacy of a specific training with eye-tracking.灌注模拟:评估眼动追踪特定训练的效果。
Perfusion. 2020 Nov;35(8):717-723. doi: 10.1177/0267659120918779. Epub 2020 May 18.